Breast cancer risk assessment across the risk continuum: Genetic and nongenetic risk factors contributing to differential model performance

Breast Cancer Research

Volumn 14, Issue 6, 2012, Pages

  Quante, Anne S ^a,b,c   Whittemore, Alice S ^d   Shriver, Tom ^a   Strauch, Konstantin ^b,c   Terry, Mary B ^a,e  

^a Howard Hughes Medical Institute   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CANCER RISK ASSESSMENT TOOL; CANCER RISK; FAMILY HISTORY; FEMALE; FOLLOW UP; GENETIC RISK; HIGH RISK POPULATION; HUMAN; INTERNATIONAL BREAST CANCER INTERVENTION; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; RISK ASSESSMENT; THEORETICAL MODEL; BREAST NEOPLASMS; COMPARATIVE STUDY; GENETICS; MALE; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; RISK; RISK FACTOR; STATISTICAL MODEL; YOUNG ADULT;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; RISK; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; YOUNG ADULT;

EID: 84868243643     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3352     Document Type: Article

References (38)

1. Smith RA, Cokkinides V, Brooks D, Saslow D, Shah M, Brawley OW. Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA: A Cancer Journal for Clinicians 61:8-30.
2. Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 2005, 97:1652-1662. 10.1093/jnci/dji372, 16288118.
3. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81:1879-1886. 10.1093/jnci/81.24.1879, 2593165.
4. Claus EB, Risch N, Thompson WD. The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat 1993, 28:115-120. 10.1007/BF00666424, 8173064.
5. Antoniou AC, Pharoah PP, Smith P, Easton DF. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 2004, 91:1580-1590. 2409934, 15381934.
6. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004, 23:1111-1130. 10.1002/sim.1668, 15057881.
7. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994, 73:643-651. 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5, 8299086.
8. Gail MH, Costantino JP, Pee D, Bondy M, Newman L, Selvan M, Anderson GL, Malone KE, Marchbanks PA, McCaskill-Stevens W, Norman SA, Simon MS, Spirtas R, Ursin G, Bernstein L. Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst 2007, 99:1782-1792. 10.1093/jnci/djm223, 18042936.
9. Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999, 91:1541-1548. 10.1093/jnci/91.18.1541, 10491430.
10. Matsuno RK, Costantino JP, Ziegler RG, Anderson GL, Li H, Pee D, Gail MH. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst 2011, 103:951-961. 10.1093/jnci/djr154, 3119648, 21562243.
11. Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 2010, 102:680-691. 10.1093/jnci/djq088, 20427433.
12. Bondy ML, Lustbader ED, Halabi S, Ross E, Vogel VG. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 1994, 86:620-625. 10.1093/jnci/86.8.620, 8003106.
13. Spiegelman D, Colditz GA, Hunter D, Hertzmark E. Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 1994, 86:600-607. 10.1093/jnci/86.8.600, 8145275.
14. Jacobi CE, de Bock GH, Siegerink B, van Asperen CJ. Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?. Breast Cancer Res Treat 2009, 115:381-390. 10.1007/s10549-008-0070-x, 18516672.
15. Anothaisintawee T, Teerawattananon Y, Wiratkapun C, Kasamesup V, Thakkinstian A. Risk prediction models of breast cancer: a systematic review of model performances. Breast Cancer Res Treat 2012, 133:1-10. 10.1007/s10549-011-1853-z, 22076477.
16. Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 2003, 40:807-814. 10.1136/jmg.40.11.807, 1735317, 14627668.
17. Euhus DM, Leitch AM, Huth JF, Peters GN. Limitations of the Gail model in the specialized breast cancer risk assessment clinic. Breast J 2002, 8:23-27. 10.1046/j.1524-4741.2002.08005.x, 11856157.
18. Pankratz VS, Hartmann LC, Degnim AC, Vierkant RA, Ghosh K, Vachon CM, Frost MH, Maloney SD, Reynolds C, Boughey JC. Assessment of the accuracy of the Gail model in women with atypical hyperplasia. J Clin Oncol 2008, 26:5374-5379. 10.1200/JCO.2007.14.8833, 2651072, 18854574.
19. Bellcross C. Approaches to applying breast cancer risk prediction models in clinical practice. Oncology Genetics 2009, 6:8.
20. Breast Cancer Risk Assessment Tool. , http://www.cancer.gov/bcrisktool
21. John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, Daly MB, O'Malley FP, Santella RM, Southey MC, Venne VL, Venter DJ, West DW, Whittemore AS, Seminara D. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 2004, 6:R375-389. 10.1186/bcr801, 468645, 15217505.
22. Kennedy DO, Agrawal M, Shen J, Terry MB, Zhang FF, Senie RT, Motykiewicz G, Santella RM. DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer. J Natl Cancer Inst 2005, 97:127-132. 10.1093/jnci/dji013, 15657342.
23. Shen J, Terry MB, Gurvich I, Liao Y, Senie RT, Santella RM. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 2007, 67:5538-5544. 10.1158/0008-5472.CAN-06-3490, 17545637.
24. Zipprich J, Terry MB, Liao Y, Agrawal M, Gurvich I, Senie R, Santella RM. Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. Cancer Res 2009, 69:2966-2972. 10.1158/0008-5472.CAN-08-3418, 2666943, 19339271.
25. Wu HC, Delgado-Cruzata L, Flom JD, Perrin M, Liao Y, Ferris J, Santella RM, Terry MB. Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the BCFR. Carcinogenesis 2012, 33:1946-52. Epub 2012 Jun 7, 10.1093/carcin/bgs201, 22678115.
26. Wu HC, Wang Q, Delgado-Cruzata L, Santella RM, Terry MB. Genomic methylation changes over time in peripheral blood mononuclear cell DNA: differences by assay type and baseline values. Cancer Epidemiol Biomarkers Prev 2012, 21:1314-8. Epub 2012 Jun 4, 10.1158/1055-9965.EPI-12-0300, 22665578.
27. Neuhausen SL, Ozcelik H, Southey MC, John EM, Godwin AK, Chung W, Iriondo-Perez J, Miron A, Santella RM, Whittemore A, Andrulis IL, Buys SS, Daly MB, Hopper JL, Seminara D, Senie RT, Terry MB. BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Breast Cancer Res Treat 2009, 116:379-386. 10.1007/s10549-008-0153-8, 2775077, 18704680.
28. Breast Cancer Risk Assessment Macro. , http://dceg.cancer.gov/bb/tools/bcrasasmacro
29. IBIS Breast Cancer Risk Evaluation Tool. , http://www.ems-trials.org/riskevaluator/
30. Gail MH, Pfeiffer RM. On criteria for evaluating models of absolute risk. Biostatistics 2005, 6:227-239. 10.1093/biostatistics/kxi005, 15772102.
31. Kalbfleisch J, Prentice R. The statistical analysis of failure time data. 2002, New York: Wiley and Sons, Second.
32. Hosmer DW, Lemeshow S. Applied logistic regression. 2000, New York: Wiley and Sons.
33. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000, 56:337-344. 10.1111/j.0006-341X.2000.00337.x, 10877287.
34. Pepe MS, Longton G. Standardizing diagnostic markers to evaluate and compare their performance. Epidemiology 2005, 16:598-603. 10.1097/01.ede.0000173041.03470.8b, 16135934.
35. The 'rmap' package. , http://www.stanford.edu/̃ggong/rmap/index.html
36. Liu L, Zhang J, Wu AH, Pike MC, Deapen D. Invasive breast cancer incidence trends by detailed race/ethnicity and age. Int J Cancer 2012, 130:395-404. 10.1002/ijc.26004, 21351091.
37. Huo D, Senie RT, Daly M, Buys SS, Cummings S, Ogutha J, Hope K, Olopade OI. Prediction of BRCA mutations using the BRCAPRO model in clinic-based African American, Hispanic, and other minority families in the United States. J Clin Oncol 2009, 27:1184-1190. 10.1200/JCO.2008.17.5869, 2667822, 19188678.
38. Boughey JC, Hartmann LC, Anderson SS, Degnim AC, Vierkant RA, Reynolds CA, Frost MH, Pankratz VS. Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. J Clin Oncol 28:3591-3596.